By affecting EGFR dimerization, internalization, and recruitment of eps15 and epsin1 to EGFR, OGN inhibited EGFR kinase activation and attenuated the downstream activators Akt and Zeb-1, which inhibited EMT of cancer cells and decreased tumorigenesis. Here, AKT1 is linked to cancer.